APPOS - Tampa


February 18th - February 19th, 2022

Agenda

Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.

All Times Listed are for the Eastern Standard Time Zone

Friday, February 18, 2022

8:00 am – 8:10 am              Horizon CME App Overview             

8:10 am – 8:15 am              Welcome, Introductions, & CE Housekeeping

8:15 am – 9:15 am             (01) Recent Progress in Cancer Drug Development: New Agents and                                                                New Strategies to Optimize Care    

                                                Rowena (Moe) Schwartz, PharmD, BCOP, FHOPA - University of Cincinnati
                                                James L Winkle - College of Pharmacy

9:15 am – 9:35 am               Break | Virtual Exhibit Hall - Meet-the-Clinician & Exhibitor Video                                                           Announcement

9:35 am – 10:35 am            (02) Strategies for Managing Patients Previously Treated for Multiple                                                         Myeloma

                                                 Pamela B. Dudkiewicz, DNP, APRN - BC, AOCNP - University of Miami                                                  Sylvester Comprehensive Cancer Center

10:35 am – 10:55 am           Break | Virtual Exhibit Hall - Meet-the-Clinician

10:55 am – 11:55 am           (03) What Should APPs Know About Imaging Studies Used to                                                                             Evaluate Tumor Response in Patients with Cancer?

                                                   James Costello, MD, PhD - Moffitt Cancer Center

11:55 am – 12:10 pm            Break | Virtual Exhibit Hall - Open Break

12:10 pm – 12:55 pm            Non-CME/CE Presentation Sponsored by Regeneron & Sanofi                                                                     Genzyme: A treatment Option for Advances NSCLC and two types of                                                       Advances Skin Cancers
                                                   Michele Charles, RN, MS, OCN

12:55 pm – 1:55 pm              (04) Managing Drug-Related Dermatologic Reactions in Patients with                                                            Cancer: A Focus on Immunotherapy and Targeted Therapies

                                                   Jonathan Leventhal, MD - Yale School of Medicine

1:55 pm – 2:55 pm                (05) How to Employ Molecular Test Results to Select and Modify                                                                      Treatment Regimens in Patients with mNSCLC

                                                  Dan Melzer, PharmD, BCOP - Moffitt Cancer Center

2:55 pm – 4:10 pm                (06) Cancer-Related Thrombosis: The Great Debate on the Best Way                                                                to Anticoagulate

                                                   Victoria Nachar, PharmD, BCOP - University of Michigan
                                                   Allison Schepers, PharmD, BCOP -University of Michigan

4:10 pm                                    Closing Comments

 

Saturday, February 19, 2022

7:10 am – 8:00 am               Non CME/CE Presentation: Morning Symposium - Sponsored by Pfizer                                                     Oncology: Clinical Trial Evidence for a CDK4/6 Inhibitor Combination                                                     Therapy Complemented by an Evaluation of Real-World Effectiveness
                                                 Kristi Orbaugh, RN, MSN, RNP, AOCN

8:00 am – 8:10 am                 Horizon CME App Overview

8:10 am – 8:15 am                 Welcome, Introductions, & CE Housekeeping

8:15 am – 9:15 am                (07) What is New with CAR T-cell Therapy?

                                                   Jennie M. Goble, PA-C - Medicine Mayo Clinic

9:15 am – 9:35 am                 Break | Virtual Exhibit Hall - Meet-the-Clinician & Exhibitor Video                                                             Announcement

9:35 am – 10:35 am               (08) COVID-19 and Cancer: Where Are We Now?

                                                   Abigail Martin, MSN, NP-C - Hope Medical Center

10:35 am – 10:55 am             Break | Virtual Exhibit Hall - Meet-the-Clinician

10:55  am – 11:55 am            (09) Strategies to Support Reproductive Decision-Making Before                                                                Initiating Cancer Treatment

                                                    Erin Taylor, MS, PA-C - MD Anderson Cancer Center

11:55 am – 12:10 pm               Break | Virtual Exhibit Hall - Open Break

12:10 pm – 12:55 pm               Non-CE Symposium Presentation Sponsored by Incyte-PEMAZYRE:                                                           PEMAZYRE (pemigatinib): The First FDA-Approved Treatment for                                                             Previously Treated, Unresectable Locally Advanced or metastatic                                                           Cholangiocarcinoma (CCA) with an FGFR2 Fusion or Rearrangement

                                                      Jacqueline Weatherly, PA-C - MD Anderson Cancer Center

12:55 pm – 1:55 pm                 (10) Head and Neck Cancers: An Overview of Treatment and                                                                             Management

                                                      Kedar Kirtane, MD - Moffitt Cancer Center

1:55 pm – 2:55 pm                    (11) The Evolving Role of Genomic Sequence Tests in Cancer                                                                              Therapeutics

                                                        J. Kevin Hicks, PharmD, PhD - Moffitt Cancer Center

2:55 pm – 3:55 pm                    (12) An Update of Interventional Radiologic Techniques Used in                                                                       Hepatic Malignancy

                                                       Beau Toskich, MD - Mayo Clinic College of Medicine and Science

3:55 pm                                        Closing Comments

$80.00